Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax®, as a therapeutic strategy for metastatic breast cancer

Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax®, as a therapeutic strategy for metastatic breast cancer

Bibliographic Details
Main Authors: Ghochikyan, Anahit, Pichugin, Alexey, Bagaev, Alexander, Davtyan, Arpine, Hovakimyan, Armine, Tukhvatulin, Amir, Davtyan, Hayk, Shcheblyakov, Dmitry, Logunov, Denis, Chulkina, Marina, Savilova, Anastasia, Trofimov, Dmitry, Nelson, Edward L, Agadjanyan, Michael G, Ataullakhanov, Ravshan I
Format: Online
Language:English
Published: BioMed Central 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261251/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261251/

Similar Items